A high-performance liquid chromatography - tandem mass spectrometry - based targeted metabolomics kidney dysfunction marker panel in human urine

Clinica Chimica Acta

Volumn 446, Issue , 2015, Pages 43-53

  Klepacki, Jacek ^a   Klawitter, Jost ^a   Klawitter, Jelena ^a,b   Thurman, Joshua M ^b   Christians, Uwe ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

High performance liquid chromatography tandem mass spectrometry (HPLC MS MS); Kidney dysfunction markers; Normal values; Tacrolimus nephrotoxicity; Urine metabolomics

Indexed keywords

CITRIC ACID; CREATININE; GLUCOSE; HIPPURIC ACID; LACTIC ACID; MOLECULAR MARKER; OXOACID; OXOGLUTARATE; SORBITOL; SUCCINIC ACID; TACROLIMUS; TRIMETHYLAMINE OXIDE; UNCLASSIFIED DRUG; URIC ACID; BIOLOGICAL MARKER;

ARTICLE; CHILD; CITRIC ACID CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIMIT OF QUANTITATION; MALE; METABOLOMICS; OXIDATIVE STRESS; PRIORITY JOURNAL; PURINE METABOLISM; REFERENCE VALUE; TANDEM MASS SPECTROMETRY; URINALYSIS; VALIDATION STUDY; ADOLESCENT; ADULT; AGED; BLOOD; KIDNEY DISEASES; MIDDLE AGED; PRESCHOOL CHILD; PROCEDURES; URINE; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOMARKERS; CHILD; CHILD, PRESCHOOL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; KIDNEY DISEASES; MALE; METABOLOMICS; MIDDLE AGED; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84928137435     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2015.04.005     Document Type: Article

References (31)

1. Wishart D.S. Metabolomics: the principles and potential applications to transplantation. Am J Transplant 2005, 5:2814-2820.
2. Bohra R., Klepacki J., Klawitter J., Thurman J.M., Christians U. Proteomics and metabolomics in renal transplantation-quo vadis?. Transpl Int 2013, 26:225-241.
3. Weiss R.H., Kim K. Metabolomics in the study of kidney diseases. Nat Rev Nephrol 2011, 8:22-33.
4. Wang J., Zhou Y., Xu M., Rong R., Guo Y., Zhu T. Urinary metabolomics in monitoring acute tubular injury of renal allografts: a preliminary report. Transplant Proc 2011, 43:3738-3742.
5. Klawitter J., Haschke M., Kahle C., Dingmann C., Leibfritz D., Christians U. Toxicodynamic effects of ciclosporin are reflected by metabolite profiles in the urine of healthy individuals after a single dose. Br J Clin Pharmacol 2010, 70:241-251.
6. Zhao Y.Y. Metabolomics in chronic kidney disease. Clin Chim Acta 2013, 422:59-69.
7. Zhao Y.Y., Cheng X.L., Wei F., et al. Intrarenal metabolomics investigation of chronic kidney disease and its TGF-β1 mechanism in induced-adenine rats using UPLC Q-TOF/HSMS/MS(E). J Proteome Res 2013, 12:692-703.
8. Zhao Y.Y., Liu J., Cheng X.L., Bai X., Lin R.C. Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS. Clin Chim Acta 2012, 413:642-649.
9. Schmitz V., Klawitter J., Bendrick-Peart J., et al. Metabolic profiles in urine reflect nephrotoxicity of sirolimus and cyclosporine following rat kidney transplantation. Nephron Exp Nephrol 2009, 111:e80-e91.
10. Klawitter J., Kushner E., Jonscher K., et al. Association of immunosuppressant-induced protein changes in the rat kidney with changes in urine metabolite patterns: a proteo-metabonomic study. J Proteome Res 2010, 9:865-875.
11. Wishart D.S. Metabolomics in monitoring kidney transplants. Curr Opin Nephrol Hypertens 2006, 15:637-642.
12. Gamagedara S., Shi H., Ma Y. Quantitative determination of taurine and related biomarkers in urine by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 2012, 402:763-770.
13. CDER U.S. Department of Health and Human Services, Food and Drug Administration, (CVM) CfDEaRaCfVM. Guidance for the industry. Bioanalytical method validation 2001, [].
14. Institute. CLS. Evaluation of precision performance of quantitative measurement methods; Approved Guideline-Second Edition. [ISBN 1-56238-56542-56239].
15. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal Chem 2003, 75:3019-3030.
16. Kark R.M. A primer of urinalysis 1964, Harper & Row, New York.
17. CLSI Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline 2008, [Wayne, PA,]. Third ed. Institute CaLS (Ed.).
18. Kvitvang H.F., Andreassen T., Adam T., Villas-Boas S.G., Bruheim P. Highly sensitive GC/MS/MS method for quantitation of amino and nonamino organic acids. Anal Chem 2011, 83:2705-2711.
19. Rappold B.A., Grant R.P. HILIC-MS/MS method development for targeted quantitation of metabolites: practical considerations from a clinical diagnostic perspective. J Sep Sci 2011, 34:3527-3537.
20. Jian W., Xu Y., Edom R.W., Weng N. Analysis of polar metabolites by hydrophilic interaction chromatography - MS/MS. Bioanalysis 2011, 3:899-912.
21. Jandera P., Hajek T., Skerikova V., Soukup J. Dual hydrophilic interaction-RP retention mechanism on polar columns: structural correlations and implementation for 2-D separations on a single column. J Sep Sci 2010, 33:841-852.
22. Kwon W., Kim J.Y., Suh S., In M.K. Simultaneous determination of creatinine and uric acid in urine by liquid chromatography-tandem mass spectrometry with polarity switching electrospray ionization. Forensic Sci Int 2012, 221:57-64.
23. Johnson D.W. A flow injection electrospray ionization tandem mass spectrometric method for the simultaneous measurement of trimethylamine and trimethylamine N-oxide in urine. J Mass Spectrom 2008, 43:495-499.
24. Kaluzna-Czaplinska J. Noninvasive urinary organic acids test to assess biochemical and nutritional individuality in autistic children. Clin Biochem 2011, 44:686-691.
25. Serkova N., Fuller T.F., Klawitter J., Freise C.E., Niemann C.U. 1H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney Int 2005, 67:1142-1151.
26. Christians U., Schmitz V., Schoning W., Bendrick-Peart J., Klawitter J., Haschke M. Toxicodynamic therapeutic drug monitoring of immunosuppressants: promises, reality, and challenges. Ther Drug Monit 2008, 30:151-158.
27. Lanaspa M.A., Andres-Hernando A., Rivard C.J., Dai Y., Li N., Berl T. ZAC1 is up-regulated by hypertonicity and decreases sorbitol dehydrogenase expression, allowing accumulation of sorbitol in kidney cells. J Biol Chem 2009, 284:19974-19981.
28. Mohan P., Safi K., Little D.M., et al. Improved patient survival in recipients of simultaneous pancreas-kidney transplant compared with kidney transplant alone in patients with type 1 diabetes mellitus and end-stage renal disease. Br J Surg 2003, 90:1137-1141.
29. Niemann C.U., Serkova N.J. Biochemical mechanisms of nephrotoxicity: application for metabolomics. Expert Opin Drug Metab Toxicol 2007, 3:527-544.
30. Wishart D.S. Metabolomics: a complementary tool in renal transplantation. Contrib Nephrol 2008, 160:76-87.
31. Christians U., Albuisson J., Klawitter J., Klawitter J. The role of metabolomics in the study of kidney diseases and in the development of diagnostic tools. Biomarkers of kidney disease 2010, 39-100. Elsevier, San Diego. C. Edelstein (Ed.).